LSOFX | QLENX | LSOFX / QLENX | |
Total Expense Ratio | 2.70 | 5.58 | 48% |
Annual Report Gross Expense Ratio | 2.75 | 5.59 | 49% |
Fund Existence | 15 years | 12 years | - |
Gain YTD | 4.400 | 15.394 | 29% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 2500 | 200% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 192M | 5.17B | 4% |
Annual Yield % from dividends | 0.76 | 6.07 | 12% |
Returns for 1 year | 5.43 | 25.30 | 21% |
Returns for 3 years | 23.07 | 92.59 | 25% |
Returns for 5 years | 34.78 | 178.75 | 19% |
Returns for 10 years | 61.53 | 141.28 | 44% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FMCCX | 48.07 | 0.27 | +0.56% |
Fidelity Advisor Stock Selec Mid Cp I | |||
THISX | 78.19 | 0.43 | +0.55% |
T. Rowe Price Health Sciences I | |||
BGGIX | 11.87 | N/A | N/A |
William Blair Global Leaders R6 | |||
WRAAX | 13.77 | -0.01 | -0.07% |
Wilmington Global Alpha Equities A | |||
AWWIX | 15.54 | -0.02 | -0.13% |
CIBC Atlas International Growth Instl |